The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence comparison of Google MedGemma and ChatGPT-5 in expert-reviewed gastrointestinal and genitourinary oncology cases.
 
Ali Zidan
No Relationships to Disclose
 
Mousa El-Sururi
No Relationships to Disclose
 
Avi Belbase
No Relationships to Disclose
 
Babar Bashir
Honoraria - Precision Oncology Saudi Summit
Consulting or Advisory Role - Fate Therapeutics; KAHR Medical; Merck/Eisai; Tempus
Speakers' Bureau - Guardant Health
Research Funding - Amgen (Inst); Artios (Inst); AstraZeneca (Inst); Avenzo Therapeutics (Inst); BeiGene (Inst); Bicycle Therapeutics (Inst); Boehringer Ingelheim (Inst); Clasp Therapeutics (Inst); Daiichi Sankyo/Lilly (Inst); Department of Defense (Inst); Elucida Oncology (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Gritstone Bio (Inst); Ikena Oncology (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Johnson & Johnson/Janssen (Inst); KAHR Medical (Inst); Kumquat Biosciences (Inst); Lyell Immunopharma (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Pionyr (Inst); RasCal (Inst); Synnovation Therapeutics (Inst); Syros Pharmaceuticals (Inst); Tarveda Therapeutics (Inst)
 
Meredith Pelster
Honoraria - Castle Biosciences (I)
Consulting or Advisory Role - Arcus Biosciences (Inst); AstraZeneca (Inst); Curio Science (Inst); CytomX Therapeutics (Inst); Elevation Oncology (Inst); EMD Serono (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Research Funding - 1200 Pharma (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Affini-T Therapeutics (Inst); Agenus (Inst); Arcus Biosciences (Inst); Artios (Inst); Astellas Pharma (Inst); BeiGene (Inst); BioNTech (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Codiak Biosciences (Inst); Compass Therapeutics (Inst); CytomX Therapeutics (Inst); Eisai (Inst); Elevation Oncology (Inst); Elicio Therapeutics (Inst); Exelixis (Inst); Fate Therapeutics (Inst); Fog Pharmaceuticals (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); HiberCell (Inst); Immune-Onc Therapeutics (Inst); IMPAC Medical Systems (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Leap Therapeutics (Inst); Neogene (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Panbela Therapeutics (Inst); Revolution Medicines (Inst); Roche (Inst); Seagen (Inst); SQZ Biotechnology (Inst); Surface Oncology (Inst); Tachyon Therapeutics (Inst); Takeda (Inst); Translational Genomics Research Institute (Inst); TransThera Sciences (Nanjing), Inc. (Inst); ZielBio (Inst)
 
Youssef Bouferraa
No Relationships to Disclose
 
Alok Khorana
Honoraria - Alnylam; Anthos Therapeutics; BMS; MJH Healthcare Holdings, LLC; Pfizer; Regeneron; Sanofi; Sirius Medical; WebMD/Medscape
Consulting or Advisory Role - Alnylam; Anthos Therapeutics; BMS; Novartis; Pfizer; Regeneron; Sanofi; Sirius Medical
Research Funding - Anthos Therapeutics; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen
 
Daniel Lin
Stock and Other Ownership Interests - BioNano Genomics
Honoraria - Agenus; AstraZeneca; Exelixis; Incyte
Consulting or Advisory Role - Agenus; AstraZeneca; Exelixis; Exelixis; Exelixis/Ipsen; Incyte
 
Steven Cohen
No Relationships to Disclose
 
Hao Xie
Consulting or Advisory Role - Cardiff Oncology (Inst); NED Biosystems, Inc. (Inst); Xilio Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BioNTech SE (Inst); Cardiff Oncology (Inst); DynamiCure Biotechnology (Inst); Innovent Biologics (Inst); Pfizer (Inst); Qurient Therapeutics (Inst); SparX Biopharmaceutical Corp (Inst); Xilio Therapeutics (Inst); Xilis (Inst)
 
Cody Eslinger
No Relationships to Disclose
 
Benjamin Garmezy
Consulting or Advisory Role - Abbvie (Inst); Adaptimmune (Inst); Adicent Therapeutics (Inst); AIQ Global (Inst); Amgen (Inst); Arcus Biosciences (Inst); Arvinas (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); EMD Serono (Inst); Exelixis (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Monte Rosa Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Rondo Therapeutics (Inst); Seagen (Inst); Specialty Networks (Inst); Takeda (Inst); Xencor (Inst)
Research Funding - Abbvie (Inst); Accutar Biotech (Inst); Adcentrx Therapeutics (Inst); Adicet Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Arvinas (Inst); AstraZeneca (Inst); Avenzo Therapeutics (Inst); AVEO (Inst); Bicycle Therapeutics (Inst); crispr therapeutics (Inst); Eikon Therapuetics (Inst); Envision Pharma Group (Inst); Exelixis (Inst); Flare Therapeutics (Inst); Halda Therapeutics (Inst); Harbour BioMed (Inst); HiberCell (Inst); IDEAYA Biosciences (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Jubilant Therapeutics (Inst); Kineta (Inst); Kinnate Biopharma (Inst); Loxo (Inst); Merck (Inst); MiNK Therapeutics (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); ProfoundBio (Inst); Roche/Genentech (Inst); Takeda (Inst); Teon Therapeutics (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst); Zenshine (Inst)
 
Benjamin Maughan
Consulting or Advisory Role - Arcus Biosciences; Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Exelixis; Janssen Oncology; Lilly; Merck; Peloton Therapeutics; Pfizer; Sanofi; Telix Pharmaceuticals; Tempus; Xencor
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Roupen Odabashian
No Relationships to Disclose